

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 5.81937777 |
| 2 | doxorubicin metabolic process (GO:0044598) | 5.81937777 |
| 3 | daunorubicin metabolic process (GO:0044597) | 5.81937777 |
| 4 | NADH metabolic process (GO:0006734) | 5.71286938 |
| 5 | low-density lipoprotein particle clearance (GO:0034383) | 5.52360338 |
| 6 | triglyceride catabolic process (GO:0019433) | 5.23217703 |
| 7 | acylglycerol catabolic process (GO:0046464) | 4.98359923 |
| 8 | neutral lipid catabolic process (GO:0046461) | 4.98359923 |
| 9 | fatty acid homeostasis (GO:0055089) | 4.75966517 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 4.75276738 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.75276738 |
| 12 | plasma lipoprotein particle clearance (GO:0034381) | 4.61888814 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.50725249 |
| 14 | L-phenylalanine catabolic process (GO:0006559) | 4.50725249 |
| 15 | oxaloacetate metabolic process (GO:0006107) | 4.48616403 |
| 16 | platelet dense granule organization (GO:0060155) | 4.37346823 |
| 17 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.32779935 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 4.30133497 |
| 19 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.26350878 |
| 20 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.26350878 |
| 21 | ethanol oxidation (GO:0006069) | 4.25353077 |
| 22 | regulation of relaxation of muscle (GO:1901077) | 4.20861137 |
| 23 | heart process (GO:0003015) | 4.15034923 |
| 24 | heart contraction (GO:0060047) | 4.15034923 |
| 25 | regulation of cholesterol esterification (GO:0010872) | 4.10185981 |
| 26 | biotin metabolic process (GO:0006768) | 4.09854758 |
| 27 | regulation of pigment cell differentiation (GO:0050932) | 4.05056358 |
| 28 | DNA deamination (GO:0045006) | 4.04259484 |
| 29 | respiratory chain complex IV assembly (GO:0008535) | 4.00679597 |
| 30 | glyoxylate metabolic process (GO:0046487) | 3.98528499 |
| 31 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.97465615 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 3.91727211 |
| 33 | fatty acid beta-oxidation (GO:0006635) | 3.89833907 |
| 34 | urea metabolic process (GO:0019627) | 3.87774605 |
| 35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.85218816 |
| 36 | diacylglycerol metabolic process (GO:0046339) | 3.83898443 |
| 37 | glycerolipid catabolic process (GO:0046503) | 3.81885670 |
| 38 | oxidative phosphorylation (GO:0006119) | 3.81434296 |
| 39 | ribosomal small subunit assembly (GO:0000028) | 3.80078934 |
| 40 | cytochrome complex assembly (GO:0017004) | 3.74648642 |
| 41 | protein carboxylation (GO:0018214) | 3.74294672 |
| 42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.74294672 |
| 43 | fatty acid catabolic process (GO:0009062) | 3.73417796 |
| 44 | urea cycle (GO:0000050) | 3.72843206 |
| 45 | lymphoid progenitor cell differentiation (GO:0002320) | 3.72656747 |
| 46 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.70780523 |
| 47 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.69217172 |
| 48 | triglyceride homeostasis (GO:0070328) | 3.69151546 |
| 49 | acylglycerol homeostasis (GO:0055090) | 3.69151546 |
| 50 | definitive hemopoiesis (GO:0060216) | 3.59405820 |
| 51 | regulation of triglyceride catabolic process (GO:0010896) | 3.59316372 |
| 52 | creatine metabolic process (GO:0006600) | 3.58391401 |
| 53 | ethanol metabolic process (GO:0006067) | 3.57149578 |
| 54 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.54284738 |
| 55 | tricarboxylic acid metabolic process (GO:0072350) | 3.52332466 |
| 56 | fatty acid oxidation (GO:0019395) | 3.51120371 |
| 57 | lipid oxidation (GO:0034440) | 3.47861294 |
| 58 | fatty acid transmembrane transport (GO:1902001) | 3.47661151 |
| 59 | aerobic respiration (GO:0009060) | 3.45954577 |
| 60 | regulation of cholesterol storage (GO:0010885) | 3.44093454 |
| 61 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.43666329 |
| 62 | carnitine shuttle (GO:0006853) | 3.37322701 |
| 63 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.36926603 |
| 64 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.35244502 |
| 65 | negative regulation of fibrinolysis (GO:0051918) | 3.33395968 |
| 66 | monocarboxylic acid catabolic process (GO:0072329) | 3.33245800 |
| 67 | regulation of fibrinolysis (GO:0051917) | 3.27946981 |
| 68 | short-chain fatty acid metabolic process (GO:0046459) | 3.27658786 |
| 69 | * acyl-CoA metabolic process (GO:0006637) | 3.25318478 |
| 70 | * thioester metabolic process (GO:0035383) | 3.25318478 |
| 71 | respiratory electron transport chain (GO:0022904) | 3.24312900 |
| 72 | gluconeogenesis (GO:0006094) | 3.23499285 |
| 73 | tricarboxylic acid cycle (GO:0006099) | 3.23313871 |
| 74 | phospholipid efflux (GO:0033700) | 3.19676468 |
| 75 | protein complex biogenesis (GO:0070271) | 3.18601212 |
| 76 | triglyceride metabolic process (GO:0006641) | 3.18009062 |
| 77 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.16710770 |
| 78 | complement activation, alternative pathway (GO:0006957) | 3.16566421 |
| 79 | primary alcohol metabolic process (GO:0034308) | 3.15576717 |
| 80 | electron transport chain (GO:0022900) | 3.14026709 |
| 81 | cell differentiation involved in metanephros development (GO:0072202) | 3.13124147 |
| 82 | quinone biosynthetic process (GO:1901663) | 3.11613827 |
| 83 | ubiquinone biosynthetic process (GO:0006744) | 3.11613827 |
| 84 | regulation of protein activation cascade (GO:2000257) | 3.11305734 |
| 85 | xenobiotic catabolic process (GO:0042178) | 3.11228574 |
| 86 | plasma lipoprotein particle remodeling (GO:0034369) | 3.10825043 |
| 87 | protein-lipid complex remodeling (GO:0034368) | 3.10825043 |
| 88 | macromolecular complex remodeling (GO:0034367) | 3.10825043 |
| 89 | * very long-chain fatty acid metabolic process (GO:0000038) | 3.10793573 |
| 90 | positive regulation of lipid storage (GO:0010884) | 3.08928983 |
| 91 | lipid storage (GO:0019915) | 3.07357831 |
| 92 | valine metabolic process (GO:0006573) | 3.06264960 |
| 93 | facial nerve structural organization (GO:0021612) | 3.06207588 |
| 94 | blood coagulation, intrinsic pathway (GO:0007597) | 3.05165141 |
| 95 | glomerulus development (GO:0032835) | 3.04294729 |
| 96 | regulation of sterol transport (GO:0032371) | 3.02521926 |
| 97 | regulation of cholesterol transport (GO:0032374) | 3.02521926 |
| 98 | acetyl-CoA metabolic process (GO:0006084) | 3.02292599 |
| 99 | acylglycerol metabolic process (GO:0006639) | 3.02011938 |
| 100 | superoxide anion generation (GO:0042554) | 3.01176791 |
| 101 | regulation of RIG-I signaling pathway (GO:0039535) | 3.00769576 |
| 102 | negative regulation of cholesterol transport (GO:0032375) | 3.00367519 |
| 103 | negative regulation of sterol transport (GO:0032372) | 3.00367519 |
| 104 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.00035145 |
| 105 | sarcomere organization (GO:0045214) | 2.99244131 |
| 106 | regulation of plasminogen activation (GO:0010755) | 2.99023425 |
| 107 | actin-myosin filament sliding (GO:0033275) | 2.97674394 |
| 108 | muscle filament sliding (GO:0030049) | 2.97674394 |
| 109 | myofibril assembly (GO:0030239) | 2.97494019 |
| 110 | regulation of complement activation (GO:0030449) | 2.97342895 |
| 111 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.96829874 |
| 112 | hexose biosynthetic process (GO:0019319) | 2.96659152 |
| 113 | 2-oxoglutarate metabolic process (GO:0006103) | 2.96513933 |
| 114 | triglyceride biosynthetic process (GO:0019432) | 2.95648693 |
| 115 | neutral lipid metabolic process (GO:0006638) | 2.95642105 |
| 116 | phospholipid homeostasis (GO:0055091) | 2.93903380 |
| 117 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.93473490 |
| 118 | neutral lipid biosynthetic process (GO:0046460) | 2.93467764 |
| 119 | acylglycerol biosynthetic process (GO:0046463) | 2.93467764 |
| 120 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.92889909 |
| 121 | positive regulation of cholesterol efflux (GO:0010875) | 2.91753175 |
| 122 | primary alcohol catabolic process (GO:0034310) | 2.90891348 |
| 123 | monosaccharide biosynthetic process (GO:0046364) | 2.90003243 |
| 124 | negative regulation of lipase activity (GO:0060192) | 2.89540092 |
| 125 | response to interferon-beta (GO:0035456) | 2.86516611 |
| 126 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.86135087 |
| 127 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.85028911 |
| 128 | brown fat cell differentiation (GO:0050873) | 2.84761648 |
| 129 | regulation of actin filament-based movement (GO:1903115) | 2.83770641 |
| 130 | epoxygenase P450 pathway (GO:0019373) | 2.83465664 |
| 131 | acyl-CoA biosynthetic process (GO:0071616) | 2.83150826 |
| 132 | thioester biosynthetic process (GO:0035384) | 2.83150826 |
| 133 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.83127713 |
| 134 | secretory granule organization (GO:0033363) | 2.83069134 |
| 135 | fibrinolysis (GO:0042730) | 2.82532194 |
| 136 | mesonephros development (GO:0001823) | 2.81963662 |
| 137 | amino-acid betaine metabolic process (GO:0006577) | 2.81138200 |
| 138 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.78931322 |
| 139 | ubiquinone metabolic process (GO:0006743) | 2.78283368 |
| 140 | cellular response to zinc ion (GO:0071294) | 2.76995346 |
| 141 | positive regulation of developmental pigmentation (GO:0048087) | 2.75589735 |
| 142 | branched-chain amino acid catabolic process (GO:0009083) | 2.74106250 |
| 143 | negative regulation of viral genome replication (GO:0045071) | 2.73707343 |
| 144 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.70574045 |
| 145 | regulation of metalloenzyme activity (GO:0048552) | 2.70461121 |
| 146 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.70161513 |
| 147 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.69298770 |
| 148 | detection of bacterium (GO:0016045) | 2.68968188 |
| 149 | cardiac myofibril assembly (GO:0055003) | 2.68473093 |
| 150 | regulation of sequestering of triglyceride (GO:0010889) | 2.66018044 |
| 151 | actin-mediated cell contraction (GO:0070252) | 2.65975604 |
| 152 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.65744680 |
| 153 | NADH dehydrogenase complex assembly (GO:0010257) | 2.65744680 |
| 154 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.65744680 |
| 155 | signal peptide processing (GO:0006465) | 2.65259889 |
| 156 | detection of other organism (GO:0098543) | 2.63895305 |
| 157 | viral genome replication (GO:0019079) | 2.63542027 |
| 158 | regulation of interleukin-8 secretion (GO:2000482) | 2.59987752 |
| 159 | bone remodeling (GO:0046849) | 2.59114517 |
| 160 | proteasome assembly (GO:0043248) | 2.57865338 |
| 161 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.53283941 |
| 162 | branched-chain amino acid metabolic process (GO:0009081) | 2.52211878 |
| 163 | negative regulation of bone mineralization (GO:0030502) | 2.50892379 |
| 164 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.50295311 |
| 165 | negative regulation of myotube differentiation (GO:0010832) | 2.49619068 |
| 166 | response to folic acid (GO:0051593) | 2.49604388 |
| 167 | mannosylation (GO:0097502) | 2.48662860 |
| 168 | negative regulation of osteoblast proliferation (GO:0033689) | 2.48333154 |
| 169 | GPI anchor biosynthetic process (GO:0006506) | 2.47906397 |
| 170 | T cell lineage commitment (GO:0002360) | 2.46890994 |
| 171 | androgen biosynthetic process (GO:0006702) | 2.45785892 |
| 172 | dendritic cell chemotaxis (GO:0002407) | 2.45540010 |
| 173 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.45499194 |
| 174 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.45499194 |
| 175 | toxin transport (GO:1901998) | 2.44709084 |
| 176 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.44529374 |
| 177 | DNA ligation (GO:0006266) | 2.43996715 |
| 178 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.43591548 |
| 179 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.43070373 |
| 180 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.41227254 |
| 181 | iron-sulfur cluster assembly (GO:0016226) | 2.41110066 |
| 182 | metallo-sulfur cluster assembly (GO:0031163) | 2.41110066 |
| 183 | positive regulation of respiratory burst (GO:0060267) | 2.40587256 |
| 184 | cellular respiration (GO:0045333) | 2.40559747 |
| 185 | negative regulation of protein localization to cell surface (GO:2000009) | 2.39533036 |
| 186 | regulation of skeletal muscle contraction (GO:0014819) | 2.37329065 |
| 187 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.36408185 |
| 188 | megakaryocyte development (GO:0035855) | 2.35724295 |
| 189 | regulation of striated muscle contraction (GO:0006942) | 2.35349122 |
| 190 | N-acetylneuraminate metabolic process (GO:0006054) | 2.33973217 |
| 191 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.33959124 |
| 192 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.33058856 |
| 193 | omega-hydroxylase P450 pathway (GO:0097267) | 2.31083817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.87629822 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.96895480 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.10229870 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.93357358 |
| 5 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.93344245 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.52689347 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.14049415 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.03566197 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.02658442 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.01879665 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.79029832 |
| 12 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.77792875 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.77656715 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.66960992 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.65342060 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.60570015 |
| 17 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.46632466 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.41023378 |
| 19 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.32163097 |
| 20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.28095927 |
| 21 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.27459523 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.23604444 |
| 23 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.22398851 |
| 24 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.21053704 |
| 25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.16541981 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.13619530 |
| 27 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.12833348 |
| 28 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.06217863 |
| 29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.00102510 |
| 30 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.98343435 |
| 31 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95704935 |
| 32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.90772147 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89532525 |
| 34 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.89390397 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87356590 |
| 36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.83211567 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.81919513 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.79800159 |
| 39 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.78413185 |
| 40 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.76808278 |
| 41 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.73796717 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72617473 |
| 43 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.72180625 |
| 44 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.70920256 |
| 45 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.68437471 |
| 46 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.68007761 |
| 47 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.66218171 |
| 48 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.65968716 |
| 49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.65856720 |
| 50 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.63208225 |
| 51 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.62920941 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62098520 |
| 53 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.62038463 |
| 54 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.61393634 |
| 55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.60191394 |
| 56 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.57648430 |
| 57 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.57500947 |
| 58 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.56823727 |
| 59 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.56391908 |
| 60 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.55991165 |
| 61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.55196369 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54693785 |
| 63 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.54560800 |
| 64 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.53708634 |
| 65 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.52748776 |
| 66 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.52651965 |
| 67 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.52357309 |
| 68 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.52254894 |
| 69 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49855806 |
| 70 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.49795872 |
| 71 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.47833614 |
| 72 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.47752069 |
| 73 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.46122746 |
| 74 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42653201 |
| 75 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41308391 |
| 76 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40722123 |
| 77 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.40232854 |
| 78 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39353903 |
| 79 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.38041779 |
| 80 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36125797 |
| 81 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32205851 |
| 82 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.32135321 |
| 83 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.31340202 |
| 84 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.31340202 |
| 85 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.31220042 |
| 86 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.30811109 |
| 87 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29409466 |
| 88 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.26539821 |
| 89 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.26052078 |
| 90 | P68_20966046_ChIP-Seq_HELA_Human | 1.26030042 |
| 91 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25999122 |
| 92 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.25714124 |
| 93 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.25550105 |
| 94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25515008 |
| 95 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.25193944 |
| 96 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.23625866 |
| 97 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20606924 |
| 98 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.20231580 |
| 99 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19604811 |
| 100 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.18003917 |
| 101 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.17529260 |
| 102 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16471206 |
| 103 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15609902 |
| 104 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.15490799 |
| 105 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.15137191 |
| 106 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.14494369 |
| 107 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.14360319 |
| 108 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.13789082 |
| 109 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.13598371 |
| 110 | AR_20517297_ChIP-Seq_VCAP_Human | 1.13136684 |
| 111 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.12608870 |
| 112 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.12322236 |
| 113 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.12187377 |
| 114 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.11540551 |
| 115 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.11165725 |
| 116 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10981177 |
| 117 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10643011 |
| 118 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.09732692 |
| 119 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09328761 |
| 120 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.07997961 |
| 121 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.07870621 |
| 122 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.07352174 |
| 123 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.06676125 |
| 124 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.06481683 |
| 125 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.06412817 |
| 126 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.06191347 |
| 127 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.06165136 |
| 128 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.06081629 |
| 129 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04186906 |
| 130 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.03897741 |
| 131 | VDR_22108803_ChIP-Seq_LS180_Human | 1.03791646 |
| 132 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.03681980 |
| 133 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03640916 |
| 134 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02924258 |
| 135 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02733681 |
| 136 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.02264837 |
| 137 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01029230 |
| 138 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.00480872 |
| 139 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.00452082 |
| 140 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99041521 |
| 141 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98955747 |
| 142 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98905399 |
| 143 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.98758738 |
| 144 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.98134995 |
| 145 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97949118 |
| 146 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.97246261 |
| 147 | P300_19829295_ChIP-Seq_ESCs_Human | 0.96488963 |
| 148 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.96273832 |
| 149 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.96005724 |
| 150 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 0.96004328 |
| 151 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.95319925 |
| 152 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.95183273 |
| 153 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.94898195 |
| 154 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94651893 |
| 155 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.94103977 |
| 156 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.94083918 |
| 157 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.94067814 |
| 158 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.93850495 |
| 159 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.93622937 |
| 160 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91498579 |
| 161 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91455668 |
| 162 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.91012456 |
| 163 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.90676761 |
| 164 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.90614252 |
| 165 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.90418188 |
| 166 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.90304401 |
| 167 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90126721 |
| 168 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.89896971 |
| 169 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89556626 |
| 170 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89525959 |
| 171 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.88922100 |
| 172 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.88790755 |
| 173 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.88724918 |
| 174 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.88598879 |
| 175 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.86569737 |
| 176 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.86422142 |
| 177 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.85801077 |
| 178 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.85799324 |
| 179 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.85530097 |
| 180 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.85125024 |
| 181 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.84537689 |
| 182 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84364328 |
| 183 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84236562 |
| 184 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.82584883 |
| 185 | ATF3_27146783_Chip-Seq_COLON_Human | 0.82498414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.33249154 |
| 2 | MP0003646_muscle_fatigue | 3.21412657 |
| 3 | MP0009840_abnormal_foam_cell | 3.20101778 |
| 4 | MP0000372_irregular_coat_pigmentation | 3.16582768 |
| 5 | MP0005666_abnormal_adipose_tissue | 3.06982327 |
| 6 | MP0003136_yellow_coat_color | 3.01991219 |
| 7 | MP0004130_abnormal_muscle_cell | 2.89445813 |
| 8 | MP0005365_abnormal_bile_salt | 2.85607083 |
| 9 | MP0005360_urolithiasis | 2.83485604 |
| 10 | MP0002971_abnormal_brown_adipose | 2.83275994 |
| 11 | MP0005075_abnormal_melanosome_morpholog | 2.79480131 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.74756471 |
| 13 | MP0009697_abnormal_copulation | 2.66213141 |
| 14 | MP0009379_abnormal_foot_pigmentation | 2.61751143 |
| 15 | MP0004381_abnormal_hair_follicle | 2.61242120 |
| 16 | MP0004185_abnormal_adipocyte_glucose | 2.57520713 |
| 17 | MP0005375_adipose_tissue_phenotype | 2.55852237 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.46034171 |
| 19 | MP0001188_hyperpigmentation | 2.39929974 |
| 20 | MP0005171_absent_coat_pigmentation | 2.36150042 |
| 21 | MP0000749_muscle_degeneration | 2.34678342 |
| 22 | MP0001835_abnormal_antigen_presentation | 2.32162489 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 2.28359144 |
| 24 | MP0006292_abnormal_olfactory_placode | 2.26696091 |
| 25 | MP0005409_darkened_coat_color | 2.22816545 |
| 26 | MP0003724_increased_susceptibility_to | 2.20726994 |
| 27 | MP0000015_abnormal_ear_pigmentation | 2.16417129 |
| 28 | MP0000003_abnormal_adipose_tissue | 2.15689796 |
| 29 | MP0001661_extended_life_span | 2.09137134 |
| 30 | MP0009785_altered_susceptibility_to | 2.08148238 |
| 31 | MP0004084_abnormal_cardiac_muscle | 2.06839881 |
| 32 | MP0005174_abnormal_tail_pigmentation | 2.02711978 |
| 33 | MP0003828_pulmonary_edema | 2.02699854 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 2.02562807 |
| 35 | MP0005085_abnormal_gallbladder_physiolo | 1.96494816 |
| 36 | MP0008875_abnormal_xenobiotic_pharmacok | 1.91357634 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.89851257 |
| 38 | MP0002009_preneoplasia | 1.85873102 |
| 39 | MP0000013_abnormal_adipose_tissue | 1.85606492 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.84663696 |
| 41 | MP0005330_cardiomyopathy | 1.81106280 |
| 42 | MP0003941_abnormal_skin_development | 1.79661204 |
| 43 | MP0004147_increased_porphyrin_level | 1.79545914 |
| 44 | MP0005671_abnormal_response_to | 1.77370879 |
| 45 | MP0005332_abnormal_amino_acid | 1.75741607 |
| 46 | MP0004087_abnormal_muscle_fiber | 1.72604204 |
| 47 | MP0004215_abnormal_myocardial_fiber | 1.68514255 |
| 48 | MP0003868_abnormal_feces_composition | 1.68475023 |
| 49 | MP0002638_abnormal_pupillary_reflex | 1.63798774 |
| 50 | MP0003763_abnormal_thymus_physiology | 1.60061638 |
| 51 | MP0004036_abnormal_muscle_relaxation | 1.59840164 |
| 52 | MP0002972_abnormal_cardiac_muscle | 1.53709534 |
| 53 | MP0001879_abnormal_lymphatic_vessel | 1.53593585 |
| 54 | MP0005334_abnormal_fat_pad | 1.53025549 |
| 55 | MP0000566_synostosis | 1.50934613 |
| 56 | MP0000759_abnormal_skeletal_muscle | 1.50862805 |
| 57 | MP0001986_abnormal_taste_sensitivity | 1.49500098 |
| 58 | MP0002095_abnormal_skin_pigmentation | 1.47611424 |
| 59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.46492399 |
| 60 | MP0002970_abnormal_white_adipose | 1.46390884 |
| 61 | MP0001666_abnormal_nutrient_absorption | 1.43882422 |
| 62 | MP0000681_abnormal_thyroid_gland | 1.43015105 |
| 63 | MP0005535_abnormal_body_temperature | 1.42716480 |
| 64 | MP0002132_abnormal_respiratory_system | 1.42632826 |
| 65 | MP0000609_abnormal_liver_physiology | 1.42601908 |
| 66 | MP0001348_abnormal_lacrimal_gland | 1.42468244 |
| 67 | MP0009115_abnormal_fat_cell | 1.40983486 |
| 68 | MP0006036_abnormal_mitochondrial_physio | 1.40520580 |
| 69 | MP0003950_abnormal_plasma_membrane | 1.37860648 |
| 70 | MP0003186_abnormal_redox_activity | 1.37646391 |
| 71 | MP0000685_abnormal_immune_system | 1.34411102 |
| 72 | MP0008775_abnormal_heart_ventricle | 1.33898108 |
| 73 | MP0001544_abnormal_cardiovascular_syste | 1.31301608 |
| 74 | MP0005385_cardiovascular_system_phenoty | 1.31301608 |
| 75 | MP0000750_abnormal_muscle_regeneration | 1.30871495 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 1.29956935 |
| 77 | MP0009333_abnormal_splenocyte_physiolog | 1.29802605 |
| 78 | MP0002396_abnormal_hematopoietic_system | 1.27029111 |
| 79 | MP0000343_altered_response_to | 1.26716557 |
| 80 | MP0009780_abnormal_chondrocyte_physiolo | 1.26118873 |
| 81 | MP0003959_abnormal_lean_body | 1.22840218 |
| 82 | MP0005025_abnormal_response_to | 1.22730506 |
| 83 | MP0002933_joint_inflammation | 1.22651386 |
| 84 | MP0002419_abnormal_innate_immunity | 1.21928894 |
| 85 | MP0003279_aneurysm | 1.21258974 |
| 86 | MP0000747_muscle_weakness | 1.20920839 |
| 87 | MP0002269_muscular_atrophy | 1.18866266 |
| 88 | MP0002876_abnormal_thyroid_physiology | 1.18185021 |
| 89 | MP0002166_altered_tumor_susceptibility | 1.17426114 |
| 90 | MP0004233_abnormal_muscle_weight | 1.17408146 |
| 91 | MP0001853_heart_inflammation | 1.17261482 |
| 92 | MP0003011_delayed_dark_adaptation | 1.17073823 |
| 93 | MP0005670_abnormal_white_adipose | 1.17071565 |
| 94 | MP0003137_abnormal_impulse_conducting | 1.16123846 |
| 95 | MP0004484_altered_response_of | 1.15972682 |
| 96 | MP0001764_abnormal_homeostasis | 1.15565149 |
| 97 | MP0005408_hypopigmentation | 1.14964563 |
| 98 | MP0000751_myopathy | 1.14796503 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 1.14513891 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 1.12822126 |
| 101 | MP0004510_myositis | 1.10384403 |
| 102 | MP0002163_abnormal_gland_morphology | 1.08128116 |
| 103 | MP0002078_abnormal_glucose_homeostasis | 1.07639323 |
| 104 | MP0009643_abnormal_urine_homeostasis | 1.06051311 |
| 105 | MP0004145_abnormal_muscle_electrophysio | 1.04948125 |
| 106 | MP0002938_white_spotting | 1.04880957 |
| 107 | MP0002452_abnormal_antigen_presenting | 1.04393621 |
| 108 | MP0006138_congestive_heart_failure | 1.03825679 |
| 109 | MP0005000_abnormal_immune_tolerance | 1.02420751 |
| 110 | MP0003567_abnormal_fetal_cardiomyocyte | 1.02236170 |
| 111 | MP0003195_calcinosis | 1.01929157 |
| 112 | MP0005387_immune_system_phenotype | 1.00600689 |
| 113 | MP0001790_abnormal_immune_system | 1.00600689 |
| 114 | MP0001542_abnormal_bone_strength | 0.99965750 |
| 115 | MP0001819_abnormal_immune_cell | 0.98987398 |
| 116 | MP0002420_abnormal_adaptive_immunity | 0.98773259 |
| 117 | MP0002332_abnormal_exercise_endurance | 0.98588783 |
| 118 | MP0005620_abnormal_muscle_contractility | 0.97667784 |
| 119 | MP0002723_abnormal_immune_serum | 0.97537307 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.96738735 |
| 121 | MP0010368_abnormal_lymphatic_system | 0.95755457 |
| 122 | MP0004272_abnormal_basement_membrane | 0.95513427 |
| 123 | MP0002106_abnormal_muscle_physiology | 0.92931779 |
| 124 | MP0002108_abnormal_muscle_morphology | 0.92237082 |
| 125 | MP0010630_abnormal_cardiac_muscle | 0.91431937 |
| 126 | MP0005452_abnormal_adipose_tissue | 0.90435031 |
| 127 | MP0001881_abnormal_mammary_gland | 0.89586370 |
| 128 | MP0001800_abnormal_humoral_immune | 0.88633358 |
| 129 | MP0003191_abnormal_cellular_cholesterol | 0.88110485 |
| 130 | MP0002998_abnormal_bone_remodeling | 0.88108448 |
| 131 | MP0005451_abnormal_body_composition | 0.87973953 |
| 132 | MP0005448_abnormal_energy_balance | 0.87816027 |
| 133 | MP0005266_abnormal_metabolism | 0.86510907 |
| 134 | MP0000604_amyloidosis | 0.84499045 |
| 135 | MP0003705_abnormal_hypodermis_morpholog | 0.81834819 |
| 136 | MP0003879_abnormal_hair_cell | 0.81800507 |
| 137 | MP0008438_abnormal_cutaneous_collagen | 0.81194536 |
| 138 | MP0003075_altered_response_to | 0.79331002 |
| 139 | MP0005083_abnormal_biliary_tract | 0.79094984 |
| 140 | MP0005464_abnormal_platelet_physiology | 0.78516047 |
| 141 | MP0004019_abnormal_vitamin_homeostasis | 0.78058198 |
| 142 | MP0005379_endocrine/exocrine_gland_phen | 0.77407991 |
| 143 | MP0000689_abnormal_spleen_morphology | 0.77403364 |
| 144 | MP0005165_increased_susceptibility_to | 0.76077183 |
| 145 | MP0000716_abnormal_immune_system | 0.75654444 |
| 146 | MP0005369_muscle_phenotype | 0.74087506 |
| 147 | MP0000598_abnormal_liver_morphology | 0.74022636 |
| 148 | MP0002006_tumorigenesis | 0.73718622 |
| 149 | MP0001186_pigmentation_phenotype | 0.72935509 |
| 150 | MP0000049_abnormal_middle_ear | 0.71446809 |
| 151 | MP0002398_abnormal_bone_marrow | 0.70881526 |
| 152 | MP0002160_abnormal_reproductive_system | 0.70035011 |
| 153 | MP0002177_abnormal_outer_ear | 0.69492410 |
| 154 | MP0002127_abnormal_cardiovascular_syste | 0.69355902 |
| 155 | MP0000733_abnormal_muscle_development | 0.69255973 |
| 156 | MP0003252_abnormal_bile_duct | 0.67391360 |
| 157 | MP0002138_abnormal_hepatobiliary_system | 0.66177431 |
| 158 | MP0009642_abnormal_blood_homeostasis | 0.66151223 |
| 159 | MP0005376_homeostasis/metabolism_phenot | 0.66042232 |
| 160 | MP0009384_cardiac_valve_regurgitation | 0.62800016 |
| 161 | MP0005647_abnormal_sex_gland | 0.58814753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Rhabdomyolysis (HP:0003201) | 4.51771109 |
| 2 | Exercise-induced myalgia (HP:0003738) | 4.15563661 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.06773423 |
| 4 | Hepatic necrosis (HP:0002605) | 3.97160987 |
| 5 | Muscle fiber inclusion bodies (HP:0100299) | 3.92693609 |
| 6 | Nemaline bodies (HP:0003798) | 3.91018476 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.89914178 |
| 8 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.85872813 |
| 9 | Deep venous thrombosis (HP:0002625) | 3.66086737 |
| 10 | Hepatocellular necrosis (HP:0001404) | 3.62245172 |
| 11 | Lipid accumulation in hepatocytes (HP:0006561) | 3.58821531 |
| 12 | Type 1 muscle fiber predominance (HP:0003803) | 3.57854240 |
| 13 | Complement deficiency (HP:0004431) | 3.57325677 |
| 14 | Increased hepatocellular lipid droplets (HP:0006565) | 3.54391155 |
| 15 | Type I transferrin isoform profile (HP:0003642) | 3.51760243 |
| 16 | Distal lower limb muscle weakness (HP:0009053) | 3.48955793 |
| 17 | Xanthomatosis (HP:0000991) | 3.39891035 |
| 18 | Renal cortical cysts (HP:0000803) | 3.39500516 |
| 19 | Mitochondrial inheritance (HP:0001427) | 3.36442125 |
| 20 | Asymmetric septal hypertrophy (HP:0001670) | 3.34429407 |
| 21 | 3-Methylglutaconic aciduria (HP:0003535) | 3.32919004 |
| 22 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.32881882 |
| 23 | Increased serum pyruvate (HP:0003542) | 3.29703956 |
| 24 | Hypothermia (HP:0002045) | 3.29257643 |
| 25 | Subaortic stenosis (HP:0001682) | 3.28717100 |
| 26 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.28717100 |
| 27 | Oligomenorrhea (HP:0000876) | 3.26895811 |
| 28 | Atrial fibrillation (HP:0005110) | 3.26727461 |
| 29 | Generalized aminoaciduria (HP:0002909) | 3.21912232 |
| 30 | Increased CSF lactate (HP:0002490) | 3.16180820 |
| 31 | Renal Fanconi syndrome (HP:0001994) | 3.15726723 |
| 32 | Acute necrotizing encephalopathy (HP:0006965) | 3.09030238 |
| 33 | Increased intramyocellular lipid droplets (HP:0012240) | 3.08561515 |
| 34 | Systemic lupus erythematosus (HP:0002725) | 3.08284818 |
| 35 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.08271960 |
| 36 | Abnormality of glycolysis (HP:0004366) | 3.07989502 |
| 37 | Increased muscle lipid content (HP:0009058) | 3.07235096 |
| 38 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.05676498 |
| 39 | Reduced antithrombin III activity (HP:0001976) | 3.04449434 |
| 40 | Lipoatrophy (HP:0100578) | 3.03196883 |
| 41 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.00289497 |
| 42 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.00289497 |
| 43 | Abnormality of complement system (HP:0005339) | 2.98517276 |
| 44 | Vertebral compression fractures (HP:0002953) | 2.97469100 |
| 45 | Primary atrial arrhythmia (HP:0001692) | 2.92934736 |
| 46 | Hyperammonemia (HP:0001987) | 2.91463575 |
| 47 | Supraventricular tachycardia (HP:0004755) | 2.90241452 |
| 48 | Calf muscle hypertrophy (HP:0008981) | 2.88777365 |
| 49 | Prolonged partial thromboplastin time (HP:0003645) | 2.88312790 |
| 50 | Hyporeflexia of lower limbs (HP:0002600) | 2.87897193 |
| 51 | Patchy hypopigmentation of hair (HP:0011365) | 2.85745924 |
| 52 | Hypertriglyceridemia (HP:0002155) | 2.83763419 |
| 53 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.81776588 |
| 54 | Respiratory difficulties (HP:0002880) | 2.81378347 |
| 55 | Dilated cardiomyopathy (HP:0001644) | 2.78900215 |
| 56 | Supraventricular arrhythmia (HP:0005115) | 2.78523822 |
| 57 | Joint hemorrhage (HP:0005261) | 2.76087739 |
| 58 | Increased variability in muscle fiber diameter (HP:0003557) | 2.74642512 |
| 59 | Type 2 muscle fiber atrophy (HP:0003554) | 2.72747689 |
| 60 | Hyperlipoproteinemia (HP:0010980) | 2.72623125 |
| 61 | Ventricular tachycardia (HP:0004756) | 2.71123631 |
| 62 | Neck muscle weakness (HP:0000467) | 2.70431373 |
| 63 | EMG: myopathic abnormalities (HP:0003458) | 2.67930837 |
| 64 | Nonprogressive disorder (HP:0003680) | 2.67301404 |
| 65 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.66427108 |
| 66 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.66427108 |
| 67 | Abnormality of glycolipid metabolism (HP:0010969) | 2.66427108 |
| 68 | Microvesicular hepatic steatosis (HP:0001414) | 2.66219638 |
| 69 | Abnormality of renal resorption (HP:0011038) | 2.63340006 |
| 70 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.62292627 |
| 71 | White forelock (HP:0002211) | 2.62167052 |
| 72 | Acanthosis nigricans (HP:0000956) | 2.62044576 |
| 73 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.62024439 |
| 74 | Dicarboxylic aciduria (HP:0003215) | 2.62024439 |
| 75 | Lactic acidosis (HP:0003128) | 2.56760445 |
| 76 | Muscle fiber splitting (HP:0003555) | 2.55036886 |
| 77 | Progressive macrocephaly (HP:0004481) | 2.54674306 |
| 78 | Sudden death (HP:0001699) | 2.54232128 |
| 79 | Exertional dyspnea (HP:0002875) | 2.53913499 |
| 80 | Muscle stiffness (HP:0003552) | 2.49991791 |
| 81 | Abnormality of urine glucose concentration (HP:0011016) | 2.49846364 |
| 82 | Glycosuria (HP:0003076) | 2.49846364 |
| 83 | Acute encephalopathy (HP:0006846) | 2.49269401 |
| 84 | Hypobetalipoproteinemia (HP:0003563) | 2.48370939 |
| 85 | Aplastic anemia (HP:0001915) | 2.47508194 |
| 86 | Exercise intolerance (HP:0003546) | 2.47383495 |
| 87 | Pulmonary artery stenosis (HP:0004415) | 2.43462768 |
| 88 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.43220095 |
| 89 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.43220095 |
| 90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.43220095 |
| 91 | Increased serum lactate (HP:0002151) | 2.41596794 |
| 92 | Hypercholesterolemia (HP:0003124) | 2.39096110 |
| 93 | Myopathic facies (HP:0002058) | 2.37261398 |
| 94 | Hemorrhage of the eye (HP:0011885) | 2.36339261 |
| 95 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.35767290 |
| 96 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.35246793 |
| 97 | Hypoalphalipoproteinemia (HP:0003233) | 2.33792030 |
| 98 | Myocardial infarction (HP:0001658) | 2.32256115 |
| 99 | Protrusio acetabuli (HP:0003179) | 2.32194292 |
| 100 | Exercise-induced muscle cramps (HP:0003710) | 2.31098193 |
| 101 | Mucopolysacchariduria (HP:0008155) | 2.31079917 |
| 102 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.31079917 |
| 103 | Abnormal protein glycosylation (HP:0012346) | 2.30143189 |
| 104 | Abnormal glycosylation (HP:0012345) | 2.30143189 |
| 105 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.30143189 |
| 106 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.30143189 |
| 107 | Muscle fiber atrophy (HP:0100295) | 2.30078776 |
| 108 | Weak cry (HP:0001612) | 2.27933343 |
| 109 | Hypolipoproteinemia (HP:0010981) | 2.27592123 |
| 110 | Bulbar palsy (HP:0001283) | 2.18067892 |
| 111 | Dysostosis multiplex (HP:0000943) | 2.17042298 |
| 112 | Increased connective tissue (HP:0009025) | 2.16726335 |
| 113 | Round ear (HP:0100830) | 2.14525922 |
| 114 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.14435099 |
| 115 | Skin nodule (HP:0200036) | 2.14421563 |
| 116 | Insulin resistance (HP:0000855) | 2.13296073 |
| 117 | Ulnar deviation of the wrist (HP:0003049) | 2.12096012 |
| 118 | Steatorrhea (HP:0002570) | 2.12067315 |
| 119 | Abnormality of the calf musculature (HP:0001430) | 2.11333432 |
| 120 | Renal tubular dysfunction (HP:0000124) | 2.10234920 |
| 121 | Infantile muscular hypotonia (HP:0008947) | 2.09313391 |
| 122 | Intrahepatic cholestasis (HP:0001406) | 2.08799231 |
| 123 | Fat malabsorption (HP:0002630) | 2.07894595 |
| 124 | Nausea (HP:0002018) | 2.06926172 |
| 125 | Respiratory failure (HP:0002878) | 2.06084330 |
| 126 | Hypoplastic left heart (HP:0004383) | 2.05861004 |
| 127 | Optic disc pallor (HP:0000543) | 2.03701964 |
| 128 | Difficulty running (HP:0009046) | 2.01767520 |
| 129 | True hermaphroditism (HP:0010459) | 2.00796517 |
| 130 | Opisthotonus (HP:0002179) | 2.00010665 |
| 131 | Palpitations (HP:0001962) | 1.99026231 |
| 132 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.98329082 |
| 133 | Proximal tubulopathy (HP:0000114) | 1.98291808 |
| 134 | Prolonged bleeding time (HP:0003010) | 1.98074215 |
| 135 | Bundle branch block (HP:0011710) | 1.96893893 |
| 136 | Osteomalacia (HP:0002749) | 1.96405015 |
| 137 | Gowers sign (HP:0003391) | 1.95467550 |
| 138 | Distal arthrogryposis (HP:0005684) | 1.94193506 |
| 139 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.93261739 |
| 140 | Cerebral edema (HP:0002181) | 1.93165865 |
| 141 | Purpura (HP:0000979) | 1.92908686 |
| 142 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.92072613 |
| 143 | Growth hormone excess (HP:0000845) | 1.90770539 |
| 144 | Delayed CNS myelination (HP:0002188) | 1.89956800 |
| 145 | Abnormal atrioventricular conduction (HP:0005150) | 1.89796247 |
| 146 | Cerebral palsy (HP:0100021) | 1.89763237 |
| 147 | Glomerulonephritis (HP:0000099) | 1.89566848 |
| 148 | Mitral stenosis (HP:0001718) | 1.89073310 |
| 149 | Myositis (HP:0100614) | 1.88729003 |
| 150 | Abnormality of the axillary hair (HP:0100134) | 1.86151632 |
| 151 | Abnormality of secondary sexual hair (HP:0009888) | 1.86151632 |
| 152 | Methylmalonic acidemia (HP:0002912) | 1.85106339 |
| 153 | Agammaglobulinemia (HP:0004432) | 1.83870428 |
| 154 | Hyperphosphatemia (HP:0002905) | 1.83275573 |
| 155 | Myoglobinuria (HP:0002913) | 1.82676106 |
| 156 | Hypoplastic heart (HP:0001961) | 1.81936325 |
| 157 | Microcytic anemia (HP:0001935) | 1.81286213 |
| 158 | Tubulointerstitial nephritis (HP:0001970) | 1.80978058 |
| 159 | Meningitis (HP:0001287) | 1.79436515 |
| 160 | Petechiae (HP:0000967) | 1.78905127 |
| 161 | Ragged-red muscle fibers (HP:0003200) | 1.77868082 |
| 162 | Thyroid-stimulating hormone excess (HP:0002925) | 1.77783150 |
| 163 | Spinal cord lesions (HP:0100561) | 1.76803227 |
| 164 | Syringomyelia (HP:0003396) | 1.76803227 |
| 165 | Abnormality of the columella (HP:0009929) | 1.76620258 |
| 166 | IgM deficiency (HP:0002850) | 1.73151525 |
| 167 | Hypoglycemic coma (HP:0001325) | 1.68851803 |
| 168 | Gastrointestinal stroma tumor (HP:0100723) | 1.67579457 |
| 169 | Methylmalonic aciduria (HP:0012120) | 1.67153912 |
| 170 | Abnormal urine phosphate concentration (HP:0012599) | 1.66973216 |
| 171 | Abnormality of the prostate (HP:0008775) | 1.65436277 |
| 172 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.65014638 |
| 173 | Abnormality of the renal cortex (HP:0011035) | 1.64945023 |
| 174 | Dry hair (HP:0011359) | 1.60738566 |
| 175 | Retrobulbar optic neuritis (HP:0100654) | 1.60434060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MUSK | 4.28414918 |
| 2 | SCYL2 | 3.33754161 |
| 3 | TESK1 | 3.20130075 |
| 4 | TTN | 3.10020334 |
| 5 | NME2 | 2.91362717 |
| 6 | TRIB3 | 2.69240697 |
| 7 | CASK | 2.66843822 |
| 8 | ERN1 | 2.62503822 |
| 9 | TNIK | 2.58431860 |
| 10 | MKNK2 | 2.53158154 |
| 11 | MYLK | 2.47863822 |
| 12 | ZAK | 2.39574133 |
| 13 | MKNK1 | 2.38139372 |
| 14 | STK24 | 2.20455086 |
| 15 | ABL2 | 2.17561955 |
| 16 | TEC | 2.11138589 |
| 17 | LIMK1 | 2.06334026 |
| 18 | STK16 | 1.98344064 |
| 19 | TXK | 1.88051984 |
| 20 | ARAF | 1.87811656 |
| 21 | TESK2 | 1.87693500 |
| 22 | MAP3K14 | 1.84876505 |
| 23 | OBSCN | 1.84145769 |
| 24 | TIE1 | 1.81738375 |
| 25 | SIK1 | 1.80941449 |
| 26 | VRK2 | 1.74182885 |
| 27 | IRAK4 | 1.72487174 |
| 28 | IRAK3 | 1.71806595 |
| 29 | PRPF4B | 1.71077309 |
| 30 | YES1 | 1.61750901 |
| 31 | BCKDK | 1.61151532 |
| 32 | KIT | 1.57654479 |
| 33 | GRK7 | 1.56775378 |
| 34 | RIPK1 | 1.49807949 |
| 35 | IKBKE | 1.48499763 |
| 36 | PDK2 | 1.48406614 |
| 37 | TRPM7 | 1.46321836 |
| 38 | EIF2AK2 | 1.46083270 |
| 39 | PIK3CA | 1.44875302 |
| 40 | NLK | 1.40323382 |
| 41 | PINK1 | 1.39341442 |
| 42 | MAP3K11 | 1.32989188 |
| 43 | TGFBR2 | 1.30353446 |
| 44 | INSRR | 1.24494999 |
| 45 | IKBKB | 1.22754731 |
| 46 | NUAK1 | 1.22485357 |
| 47 | STK38L | 1.21729744 |
| 48 | BTK | 1.21056590 |
| 49 | DAPK3 | 1.18587817 |
| 50 | ADRBK2 | 1.16814165 |
| 51 | JAK3 | 1.13129681 |
| 52 | MAPKAPK5 | 1.13079405 |
| 53 | NEK9 | 1.11637992 |
| 54 | BMPR2 | 1.10720725 |
| 55 | FGFR4 | 1.08712955 |
| 56 | EIF2AK3 | 1.06944480 |
| 57 | FLT3 | 1.06411535 |
| 58 | PIM2 | 1.06248381 |
| 59 | VRK1 | 1.06164753 |
| 60 | DDR2 | 1.05608009 |
| 61 | PIK3CG | 1.05408438 |
| 62 | TNK2 | 1.03120154 |
| 63 | BMPR1B | 1.02870002 |
| 64 | MAP4K1 | 0.98255048 |
| 65 | MAP3K6 | 0.98065748 |
| 66 | EPHA2 | 0.96104865 |
| 67 | LATS1 | 0.95431033 |
| 68 | MAP3K3 | 0.95233220 |
| 69 | ILK | 0.94249891 |
| 70 | PIM1 | 0.94145948 |
| 71 | MAPK11 | 0.87481095 |
| 72 | PKN2 | 0.87108376 |
| 73 | MOS | 0.85157031 |
| 74 | MAP3K1 | 0.84331993 |
| 75 | CAMK2G | 0.82861340 |
| 76 | PRKAA1 | 0.81617821 |
| 77 | CLK1 | 0.79527165 |
| 78 | SRPK1 | 0.79222143 |
| 79 | EPHB2 | 0.78124156 |
| 80 | SIK3 | 0.77864143 |
| 81 | GRK1 | 0.77615120 |
| 82 | PLK4 | 0.77026768 |
| 83 | MARK3 | 0.74145589 |
| 84 | TGFBR1 | 0.73807929 |
| 85 | PTK2 | 0.73563264 |
| 86 | SGK2 | 0.73217881 |
| 87 | CDK8 | 0.71594921 |
| 88 | AKT2 | 0.71560102 |
| 89 | IRAK1 | 0.71371819 |
| 90 | RPS6KA6 | 0.71076721 |
| 91 | STK4 | 0.70461320 |
| 92 | NEK6 | 0.70029772 |
| 93 | SYK | 0.69019383 |
| 94 | CHUK | 0.68415636 |
| 95 | CAMK1 | 0.68362942 |
| 96 | MAP2K7 | 0.67102555 |
| 97 | PDPK1 | 0.67015611 |
| 98 | RPS6KL1 | 0.66580038 |
| 99 | RPS6KC1 | 0.66580038 |
| 100 | PRKD1 | 0.66444568 |
| 101 | LYN | 0.65998052 |
| 102 | MAPK13 | 0.64593865 |
| 103 | TBK1 | 0.64578701 |
| 104 | PHKG2 | 0.64561096 |
| 105 | PHKG1 | 0.64561096 |
| 106 | EPHB1 | 0.62806039 |
| 107 | DMPK | 0.61847090 |
| 108 | PRKG2 | 0.61131819 |
| 109 | ICK | 0.61129646 |
| 110 | KDR | 0.60000952 |
| 111 | PRKACG | 0.58877957 |
| 112 | SMG1 | 0.58785068 |
| 113 | CDK3 | 0.57246628 |
| 114 | MAP3K12 | 0.56012134 |
| 115 | ZAP70 | 0.54694507 |
| 116 | RPS6KA5 | 0.54648976 |
| 117 | PKN1 | 0.54416239 |
| 118 | MAP2K1 | 0.54150135 |
| 119 | MAPK4 | 0.53905036 |
| 120 | PRKAA2 | 0.53616255 |
| 121 | MAP2K3 | 0.53132056 |
| 122 | GSK3A | 0.52579581 |
| 123 | DAPK1 | 0.51115121 |
| 124 | PDGFRA | 0.50843734 |
| 125 | PAK4 | 0.50619519 |
| 126 | ERBB3 | 0.50479810 |
| 127 | MAPK15 | 0.49988210 |
| 128 | NEK1 | 0.49694461 |
| 129 | MAPKAPK3 | 0.49373262 |
| 130 | ACVR1B | 0.48957928 |
| 131 | RPS6KB2 | 0.45669574 |
| 132 | CAMK2D | 0.45200692 |
| 133 | GRK5 | 0.44928096 |
| 134 | TLK1 | 0.44743761 |
| 135 | PRKCE | 0.44632453 |
| 136 | MST1R | 0.43054065 |
| 137 | PBK | 0.42843535 |
| 138 | MAPK7 | 0.42150800 |
| 139 | CAMK4 | 0.41641069 |
| 140 | LCK | 0.41441915 |
| 141 | TYK2 | 0.39645087 |
| 142 | TAOK2 | 0.39477706 |
| 143 | MAPK12 | 0.38885796 |
| 144 | MAP2K6 | 0.37556065 |
| 145 | MAPKAPK2 | 0.37511408 |
| 146 | CDK9 | 0.37469090 |
| 147 | FES | 0.36292498 |
| 148 | LRRK2 | 0.35393239 |
| 149 | HCK | 0.35338478 |
| 150 | CAMKK2 | 0.35327384 |
| 151 | LMTK2 | 0.34812449 |
| 152 | AURKA | 0.34727363 |
| 153 | PAK1 | 0.34447202 |
| 154 | PAK2 | 0.32905049 |
| 155 | CDC42BPA | 0.32686353 |
| 156 | MAP2K2 | 0.32662441 |
| 157 | MAP3K13 | 0.32035304 |
| 158 | BRAF | 0.31712602 |
| 159 | CDK6 | 0.29711882 |
| 160 | MTOR | 0.29243448 |
| 161 | EEF2K | 0.29079895 |
| 162 | MAPK3 | 0.29052955 |
| 163 | PRKACA | 0.28448055 |
| 164 | EPHA3 | 0.27393723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.32048085 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.19349674 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 2.99979346 |
| 4 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.98756140 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.88921963 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.88829380 |
| 7 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.87733791 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 2.67291208 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.45714010 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.41919714 |
| 11 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.39968390 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.36727088 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.25573806 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.21231563 |
| 15 | * Fatty acid elongation_Homo sapiens_hsa00062 | 2.17835569 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 2.10465173 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.07797355 |
| 18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.04499668 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.04064554 |
| 20 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.01095378 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.98179889 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.94182113 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.93693012 |
| 24 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.91721590 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.85874136 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.81012891 |
| 27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.79060338 |
| 28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.76223685 |
| 29 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.75897405 |
| 30 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.75102746 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.69011898 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.67790838 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.63434275 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.57735857 |
| 35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.55567522 |
| 36 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.53654636 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.52061967 |
| 38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.46045121 |
| 39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.44659847 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 1.42613663 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.42008538 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.41910233 |
| 43 | DNA replication_Homo sapiens_hsa03030 | 1.41340726 |
| 44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.40815114 |
| 45 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.39857675 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.39505745 |
| 47 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.37551388 |
| 48 | Allograft rejection_Homo sapiens_hsa05330 | 1.37050735 |
| 49 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.36710744 |
| 50 | Basal transcription factors_Homo sapiens_hsa03022 | 1.34931999 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.32809507 |
| 52 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.30245864 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.27940583 |
| 54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.26608535 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.26586632 |
| 56 | RNA polymerase_Homo sapiens_hsa03020 | 1.26201133 |
| 57 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.23960079 |
| 58 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.23934611 |
| 59 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.23105013 |
| 60 | Base excision repair_Homo sapiens_hsa03410 | 1.21205121 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.20544699 |
| 62 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16730208 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.15632654 |
| 64 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.15169999 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.15126567 |
| 66 | Measles_Homo sapiens_hsa05162 | 1.14035043 |
| 67 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.13095960 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.12239935 |
| 69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.09638010 |
| 70 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.04758297 |
| 71 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.03794060 |
| 72 | Proteasome_Homo sapiens_hsa03050 | 1.01794529 |
| 73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.01194837 |
| 74 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.01128124 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98662314 |
| 76 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98444712 |
| 77 | RNA degradation_Homo sapiens_hsa03018 | 0.97663518 |
| 78 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96757555 |
| 79 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.93726204 |
| 80 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.92348388 |
| 81 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.92239220 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.90813910 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87795818 |
| 84 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.87167981 |
| 85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85667275 |
| 86 | Purine metabolism_Homo sapiens_hsa00230 | 0.84278817 |
| 87 | Bile secretion_Homo sapiens_hsa04976 | 0.84211099 |
| 88 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.78943995 |
| 89 | Mismatch repair_Homo sapiens_hsa03430 | 0.78897633 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78374733 |
| 91 | Malaria_Homo sapiens_hsa05144 | 0.78004391 |
| 92 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.77206517 |
| 93 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.76493788 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.74708407 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.73793873 |
| 96 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.73322920 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.73116101 |
| 98 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.68499567 |
| 99 | Viral myocarditis_Homo sapiens_hsa05416 | 0.66631739 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66426454 |
| 101 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64985411 |
| 102 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.64705861 |
| 103 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.63951914 |
| 104 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.62691578 |
| 105 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.62679515 |
| 106 | Lysosome_Homo sapiens_hsa04142 | 0.62096207 |
| 107 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.61801122 |
| 108 | Asthma_Homo sapiens_hsa05310 | 0.59611921 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.59110220 |
| 110 | Retinol metabolism_Homo sapiens_hsa00830 | 0.58978352 |
| 111 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.57527781 |
| 112 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56165504 |
| 113 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53859503 |
| 114 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.53421612 |
| 115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52259875 |
| 116 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51239693 |
| 117 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50552183 |
| 118 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50433810 |
| 119 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.49210134 |
| 120 | Lysine degradation_Homo sapiens_hsa00310 | 0.46960016 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.46210562 |
| 122 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45940732 |
| 123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45863228 |
| 124 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45174405 |
| 125 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41506107 |
| 126 | Leishmaniasis_Homo sapiens_hsa05140 | 0.40588056 |
| 127 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40281957 |
| 128 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39833440 |
| 129 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39616954 |
| 130 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39249131 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38648068 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36063611 |
| 133 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35484874 |
| 134 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33839375 |
| 135 | ABC transporters_Homo sapiens_hsa02010 | 0.33797070 |
| 136 | Apoptosis_Homo sapiens_hsa04210 | 0.33288483 |
| 137 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.32590224 |
| 138 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.32479281 |
| 139 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.31373796 |
| 140 | Influenza A_Homo sapiens_hsa05164 | 0.30978659 |
| 141 | Legionellosis_Homo sapiens_hsa05134 | 0.30422003 |
| 142 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29157361 |
| 143 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.27529096 |
| 144 | Prion diseases_Homo sapiens_hsa05020 | 0.21031012 |
| 145 | Mineral absorption_Homo sapiens_hsa04978 | 0.20801091 |
| 146 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20090365 |
| 147 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.17252471 |
| 148 | * Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.13585507 |
| 149 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.10448727 |
| 150 | Pertussis_Homo sapiens_hsa05133 | 0.05117223 |

